Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study

被引:3
作者
Ciardullo, Stefano [1 ,2 ,8 ,9 ]
Morabito, Gabriella [3 ,4 ]
Rea, Federico [3 ,4 ]
Savare, Laura [3 ,5 ,6 ]
Perseghin, Gianluca [1 ,2 ]
Corrao, Giovanni [3 ,4 ,7 ]
机构
[1] Policlin Monza, Dept Med & Rehabil, I-20900 Monza, Italy
[2] Univ Milano Bicocca, Sch Med & Surg, I-20126 Milan, Italy
[3] Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, I-20126 Milan, Italy
[4] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Unit Biostat Epidemiol & Publ Hlth, Lab Healthcare Res & Pharmacoepidemiol, I-20126 Milan, Italy
[5] Politecn Milan, Dept Math, MOX Lab Modeling & Sci Comp, I-20126 Milan, Italy
[6] CHDS Ctr Hlth Data Sci, Human Technopole, I-20126 Milan, Italy
[7] Directorate Gen Hlth, I-20124 Milan, Italy
[8] Univ Milano Bicocca, Dept Med & Surg, Via Modigliani 10, I-20900 Monza, MB, Italy
[9] Policlin Monza, Dept Med & Rehabil, Via Modigliani 10, I-20900 Monza, MB, Italy
关键词
liver mortality; NAFLD; epidemiology; diabetes; TRANSIENT ELASTOGRAPHY; DISEASE; PREVALENCE; CIRRHOSIS;
D O I
10.1210/clinem/dgae182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Patients with diabetes are at increased risk of dying from liver-related events, but little is known on whether this increased risk has changed in recent years.Objective The aim of the present study is to describe time trends in cause-specific liver-related mortality in people with and without diabetes from the general Italian population.Methods Data were retrieved from the health care utilization databases of Lombardy, a region of Italy that accounts for about 16% (almost 10 million) of its population. Annual cause-specific mortality rates and proportionate mortality were computed among individuals with and without diabetes from 2010 to 2019. Liver-related deaths were categorized as viral, alcohol related, and nonviral nonalcohol related (NVNA).Results Liver diseases were responsible for 2% and 1% of deaths in people with and without diabetes (2019). Among patients with diabetes, the crude mortality rate for liver diseases decreased from 1.13 to 0.64 deaths per 1000 person-years from 2010 to 2019. The largest proportion of liver-related deaths was attributable to NVNA diseases and it increased from 63% in 2010 to 68% in 2019, with a corresponding relative reduction of viral causes (from 27% to 23%). The standardized mortality ratio for patients with diabetes was 3.35 (95% CI 2.96-3.76) for NVNA, 1.66 (95% CI 1.33-2.01) for viral hepatitis, and 1.61 (95% CI 1.13-2.17) for alcoholic liver disease and it remained relatively stable over time. Excess mortality risk in patients with diabetes for liver-related mortality was higher than for cardiovascular mortality and cancer.Conclusion While liver-related mortality rates decreased significantly among patients with diabetes, NVNA causes made up the majority of cases. Excess mortality for liver-related causes in patients with diabetes compared with controls remained constant in the studied period.
引用
收藏
页码:2513 / 2519
页数:7
相关论文
共 37 条
  • [1] Athanasiou S., 2024, ZENODO
  • [2] Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million US Adults
    Campbell, Peter T.
    Newton, Christina C.
    Patel, Alpa V.
    Jacobs, Eric J.
    Gapstur, Susan M.
    [J]. DIABETES CARE, 2012, 35 (09) : 1835 - 1844
  • [3] Exploring the landscape of steatotic liver disease in the general US population
    Ciardullo, Stefano
    Carbone, Marco
    Invernizzi, Pietro
    Perseghin, Gianluca
    [J]. LIVER INTERNATIONAL, 2023, : 2425 - 2433
  • [4] Trends in prevalence of probable fibrotic non-alcoholic steatohepatitis in the United States, 1999-2016
    Ciardullo, Stefano
    Perseghin, Gianluca
    [J]. LIVER INTERNATIONAL, 2023, 43 (02) : 340 - 344
  • [5] Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
    Ciardullo, Stefano
    Perseghin, Gianluca
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 190
  • [6] Prolonged use of proton pump inhibitors and risk of type 2 diabetes: Results from a large population-based nested case-control study
    Ciardullo, Stefano
    Rea, Federico
    Savare, Laura
    Morabito, Gabriella
    Perseghin, Gianluca
    Corrao, Giovanni
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07) : E2671 - E2679
  • [7] Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population
    Ciardullo, Stefano
    Monti, Tommaso
    Grassi, Guido
    Mancia, Giuseppe
    Perseghin, Gianluca
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 (08) : 1621 - 1627
  • [8] High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among US Adults With Type 2 Diabetes
    Ciardullo, Stefano
    Monti, Tommaso
    Perseghin, Gianluca
    [J]. DIABETES CARE, 2021, 44 (02) : 519 - 525
  • [9] Nonalcoholic fatty liver disease - An underrecognized cause of cryptogenic cirrhosis
    Clark, JM
    Diehl, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (22): : 3000 - 3004
  • [10] Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real -world evidence from Italy
    Corrao, Giovanni
    Compagnoni, Matteo Monzio
    Cantarutti, Anna
    Rea, Federico
    Merlino, Luca
    Catapano, Alberico L.
    Mancia, Giuseppe
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164